Skip to main content
Top

2016 | OriginalPaper | Hoofdstuk

19 Prenatale screening, prenatale diagnostiek en pre-implantatie genetische diagnostiek

Auteurs : prof.dr. M.J. Heineman, prof.dr. J.L.H. Evers, prof.dr. L.F.A.G. Massuger, prof.dr. E.A.P. Steegers

Gepubliceerd in: Obstetrie en gynaecologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De keuze tussen geen onderzoek, prenatale screening of prenatale diagnostiek kan het beste door de ouders zelf worden gemaakt. De keuze voor prenatale diagnostiek wordt zelden lichtvaardig gemaakt, onder meer vanwege het proceduregerelateerde risico. Tien procent van de uitslagen van prenatale diagnostiek is afwijkend. Niet alle afwijkende uitslagen zijn aanleiding tot zwangerschapsafbreking. De begeleiding hoort thuis bij gynaecoloog, klinisch geneticus, genetic counseler, maatschappelijk werker, huisarts en verloskundige.
Literatuur
go back to reference Bennett RL, Steinhaus KA, Uhrich SB, et al. Recommendations for standardized human pedigree nomenclature. Am J Hum Genet. 1995;56:745–52.PubMedPubMedCentral Bennett RL, Steinhaus KA, Uhrich SB, et al. Recommendations for standardized human pedigree nomenclature. Am J Hum Genet. 1995;56:745–52.PubMedPubMedCentral
go back to reference Boormans EM, Birnie E, Oepkes D, et al. Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis. Obstet Gynecol. 2010;115:297–303.CrossRefPubMed Boormans EM, Birnie E, Oepkes D, et al. Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis. Obstet Gynecol. 2010;115:297–303.CrossRefPubMed
go back to reference Broekhuizen FF Misoprostol, its use in obstetrics and gynecology. Curr Probl Obstet Gynecol Fertil. 2000;23:193–224. Broekhuizen FF Misoprostol, its use in obstetrics and gynecology. Curr Probl Obstet Gynecol Fertil. 2000;23:193–224.
go back to reference Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401. Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401.
go back to reference College van Procureurs-Generaal. Aanwijzing vervolgingsbeslissing levensbeëindiging niet op verzoek en late zwangerschapsafbreking. Staatscourant. 2007;(46). College van Procureurs-Generaal. Aanwijzing vervolgingsbeslissing levensbeëindiging niet op verzoek en late zwangerschapsafbreking. Staatscourant. 2007;(46).
go back to reference Evans JA, Hamerton JL, Robinson A, eds. Children and young adults with sex chromosome aneuploidy. Follow-up, clinical and molecular studies. March of Dimes Birth Defects Foundation. Birth Def. 1990;26(4). Evans JA, Hamerton JL, Robinson A, eds. Children and young adults with sex chromosome aneuploidy. Follow-up, clinical and molecular studies. March of Dimes Birth Defects Foundation. Birth Def. 1990;26(4).
go back to reference Gezondheidsraad. Wet bevolkingsonderzoek: aanzet tot een landelijk programma voor prenatale screening. 2006. Gezondheidsraad. Wet bevolkingsonderzoek: aanzet tot een landelijk programma voor prenatale screening. 2006.
go back to reference Hahnemann JM, Vejerslev LO. Accuracy of cytogenetic findings on chorionic villus sampling (CVS) - diagnostic consequences of CVS mosaicism and non-mosaic discrepancy on centres contributing to Eucromic 1986-1992. Prenat Diagn. 1997;17:801–20.CrossRefPubMed Hahnemann JM, Vejerslev LO. Accuracy of cytogenetic findings on chorionic villus sampling (CVS) - diagnostic consequences of CVS mosaicism and non-mosaic discrepancy on centres contributing to Eucromic 1986-1992. Prenat Diagn. 1997;17:801–20.CrossRefPubMed
go back to reference Harper JC, Wilton L, Traeger-Synodinos J, et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update. 2012 Feb 16. [Epub ahead of print] Harper JC, Wilton L, Traeger-Synodinos J, et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update. 2012 Feb 16. [Epub ahead of print]
go back to reference Jaarverslagen Werkgroep Prenatale Diagnostiek. Utrecht: NVOG. Jaarverslagen Werkgroep Prenatale Diagnostiek. Utrecht: NVOG.
go back to reference Korenromp M. Parental adaptation to termination of pregnancy for fetal anomalies [proefschrift]. Utrecht, 2006. Korenromp M. Parental adaptation to termination of pregnancy for fetal anomalies [proefschrift]. Utrecht, 2006.
go back to reference Kuc S, Wortelboer EJ, Rijn BB van, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66:225–39.CrossRefPubMed Kuc S, Wortelboer EJ, Rijn BB van, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66:225–39.CrossRefPubMed
go back to reference Li Y, Page-Christiaens GCML, Gille JJP, et al. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27:11–7.CrossRefPubMed Li Y, Page-Christiaens GCML, Gille JJP, et al. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27:11–7.CrossRefPubMed
go back to reference Los FJ, Berg C van den, Wildschut HIJ, et al. The diagnostic performance of cytogenetic investigation in amniotic fluid cells and chorionic villi. Prenat Diagn. 2011;21:1150–8.CrossRef Los FJ, Berg C van den, Wildschut HIJ, et al. The diagnostic performance of cytogenetic investigation in amniotic fluid cells and chorionic villi. Prenat Diagn. 2011;21:1150–8.CrossRef
go back to reference Mitelman F, ed. An international system for human cytogenetic nomenclature. Basel: Karger, 1995. Mitelman F, ed. An international system for human cytogenetic nomenclature. Basel: Karger, 1995.
go back to reference Nagel HTC, Knegt AC, Kloosterman MD, et al. Invasieve prenatale diagnostiek in Nederland, 1991-2000: aantallen ingrepen, indicaties en gevonden afwijkingen. Ned Tijdschr Geneeskd. 2004;148:1538–43.PubMed Nagel HTC, Knegt AC, Kloosterman MD, et al. Invasieve prenatale diagnostiek in Nederland, 1991-2000: aantallen ingrepen, indicaties en gevonden afwijkingen. Ned Tijdschr Geneeskd. 2004;148:1538–43.PubMed
go back to reference Overleggroep Late Zwangerschapsafbreking. Late zwangerschapsafbreking: zorgvuldigheid en toetsing. Rijswijk: Ministerie van VWS, 1998. Overleggroep Late Zwangerschapsafbreking. Late zwangerschapsafbreking: zorgvuldigheid en toetsing. Rijswijk: Ministerie van VWS, 1998.
go back to reference Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin’s principles and practice of medical genetics, 3rd ed. New York: Churchill Livingstone, 1997. Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin’s principles and practice of medical genetics, 3rd ed. New York: Churchill Livingstone, 1997.
go back to reference Scheffer PG, Schoot CE van der, Page-Christiaens GCML, et al. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol. 2010;115:117–26.CrossRefPubMed Scheffer PG, Schoot CE van der, Page-Christiaens GCML, et al. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol. 2010;115:117–26.CrossRefPubMed
go back to reference Scheffer PG, Schoot CE van der, Page-Christiaens GCML, Haas M de. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunized pregnant women: evaluation of a 7-year clinical experience. BJOG. 2011;118:1340–8.CrossRefPubMed Scheffer PG, Schoot CE van der, Page-Christiaens GCML, Haas M de. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunized pregnant women: evaluation of a 7-year clinical experience. BJOG. 2011;118:1340–8.CrossRefPubMed
go back to reference Scheffer PG, Ait Soussan A, Verhagen OJHM, et al. Noninvasive fetal genotyping of human platelet antigen-1a. BJOG. 2011;118:1392–5.CrossRefPubMed Scheffer PG, Ait Soussan A, Verhagen OJHM, et al. Noninvasive fetal genotyping of human platelet antigen-1a. BJOG. 2011;118:1392–5.CrossRefPubMed
go back to reference Schielen PCJI, et al. Risicoschatting voor downsyndroom/neuraalbuisdefecten door analyse van triple test parameters in maternaal serum 1995-1999. Bilthoven: RIVM, 2002. Schielen PCJI, et al. Risicoschatting voor downsyndroom/neuraalbuisdefecten door analyse van triple test parameters in maternaal serum 1995-1999. Bilthoven: RIVM, 2002.
go back to reference Smith K, Lowther G, Maher E, et al. The predictive value of findings of the common aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome abnormalities at CVS: Experience from the ACC U.K. Collaborative Study. Prenat Diagn. 1999;19:817–26.CrossRefPubMed Smith K, Lowther G, Maher E, et al. The predictive value of findings of the common aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome abnormalities at CVS: Experience from the ACC U.K. Collaborative Study. Prenat Diagn. 1999;19:817–26.CrossRefPubMed
go back to reference Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down’s syndrome based on tests performed during the first and second trimesters. N Engl J Med. 1999;341:461–7.CrossRefPubMed Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down’s syndrome based on tests performed during the first and second trimesters. N Engl J Med. 1999;341:461–7.CrossRefPubMed
go back to reference Wald NJ, Rodeck C, Hackshaw AK, et al.; SURUSS Research Group. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003;7:1–77.CrossRef Wald NJ, Rodeck C, Hackshaw AK, et al.; SURUSS Research Group. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003;7:1–77.CrossRef
go back to reference Wortelboer EJ, Koster MPH, Stoutenbeek P, et al. Fifteen years of triple tests in the Netherlands; the life cycle of a screening test. Prenat Diagn. 2008;28:950–5.CrossRefPubMed Wortelboer EJ, Koster MPH, Stoutenbeek P, et al. Fifteen years of triple tests in the Netherlands; the life cycle of a screening test. Prenat Diagn. 2008;28:950–5.CrossRefPubMed
go back to reference Wright CF, Burton H. The use of cell-free nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15:139–51.CrossRefPubMed Wright CF, Burton H. The use of cell-free nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15:139–51.CrossRefPubMed
Metagegevens
Titel
19 Prenatale screening, prenatale diagnostiek en pre-implantatie genetische diagnostiek
Auteurs
prof.dr. M.J. Heineman
prof.dr. J.L.H. Evers
prof.dr. L.F.A.G. Massuger
prof.dr. E.A.P. Steegers
Copyright
2016
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-1191-0_19